Related Experiment Video

Updated: Jul 10, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

[Burden of comorbidities in heart failure patients hospitalized at the Abidjan Heart Institute]

K A Adoubi1, E Soya2, K D Bamba2

  • 1Institut de cardiologie d'Abidjan, Abidjan, Cote d'Ivoire; Université de Bouaké, Bouaké, Cote d'Ivoire.

Annales De Cardiologie Et D'Angeiologie
|April 1, 2020
PubMed

Insights

Comorbidities are frequent in heart failure patients, with hypertension and anemia being most common. These conditions significantly worsen prognosis and increase mortality risk in heart failure management.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Heart failure is a complex condition often accompanied by multiple comorbidities.
  • Understanding the impact of these comorbidities is crucial for effective patient management and prognosis.
  • Previous studies have highlighted the prevalence of comorbidities, but their specific impact on heart failure prognosis requires further investigation.

Purpose of the Study:

  • To assess the prevalence and impact of comorbidities in hospitalized heart failure patients.
  • To analyze the relationship between comorbidities, heart failure etiologies, and patient outcomes.
  • To determine the prognostic significance of individual and multiple comorbidities in heart failure.

Main Methods:

  • A prospective cohort study involving 302 adult heart failure patients admitted to the Cardiology Institute of Abidjan.
  • Data collection included patient demographics, comorbidities, heart failure etiology, and follow-up for 12 months.
  • Statistical analyses, including univariate and multivariate analyses (Cox model, Kaplan-Meier curves), were used to evaluate the impact of comorbidities on mortality.

Main Results:

  • The most common comorbidities were high blood pressure (48%), anemia (43.7%), and kidney dysfunction (41.3%).
  • Patients had an average of 3.4 comorbidities, with prevalence increasing with age.
  • Hepatic dysfunction and a high Charlson index score were identified as significant risk factors for mortality.

Conclusions:

  • Comorbidities are highly prevalent in heart failure patients.
  • The presence and number of comorbidities significantly impact the prognosis of heart failure.
  • Identifying and managing comorbidities is essential for improving outcomes in heart failure patients.
Abstract

Keywords:
Afrique subsaharienneCharlson indexComorbiditiesComorbiditésHeart failureIndex de CharlsonInsuffisance cardiaquePrevalencePrognosisPronosticPrévalenceSub-Saharan Africa

More Related Videos

Clinical Application of Phase Angle and BIVA Z-Score Analyses in Patients Admitted to an Emergency Department with Acute Heart Failure04:05

Clinical Application of Phase Angle and BIVA Z-Score Analyses in Patients Admitted to an Emergency Department with Acute Heart Failure

Published on: June 30, 2023

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.